The exact etiopathology of chilblains observed during the Coronavirus Disease 2019 (COVID-19) pandemic is still unclear. Initially, SARS-CoV-2 appeared as the obvious causing agent, but two years of various investigations have failed to convincingly support its direct implication. Most affected individuals have no detectable virus, no anti-SARS-CoV-2 antibodies and no symptoms of COVID-19. Analyses of skin biopsies similarly failed to unambiguously demonstrate presence of the virus or its genome. In a recent hypothesis, SARS-CoV-2 would cause the lesions before being promptly eliminated by unusually strong type I interferon responses. With others, we feel that environmental factors have not been sufficiently considered, in particular cold exposure related to unprecedented containment measures. The cause of pandemic chilblains remains a stimulating puzzle which warrants further investigation.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942450 | PMC |
http://dx.doi.org/10.1016/j.clim.2022.108984 | DOI Listing |
J Med Case Rep
June 2024
University Center for Primary Care and Public Health, Unisanté, Lausanne, Switzerland.
Acta Dermatovenerol Alp Pannonica Adriat
December 2023
Department of Dermatovenereology, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia.
This review article focuses on cutaneous manifestations in schoolchildren and adolescents 6 to 18 years old connected with various aspects of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, including personal protective equipment (PPE), SARS-CoV-2 infection, and the SARS-CoV-2 vaccine. The use of PPE has been associated with mask-related acne due to microbiome dysbiosis and disruption of skin homeostasis, leading to the emergence of new acne or exacerbation of preexisting acne. Chilblain-like lesions, erythema multiforme-like eruptions, and cutaneous manifestations of multisystem inflammatory syndrome related to SARS-CoV-2 are the most commonly described skin manifestations of SARS-CoV-2 infection.
View Article and Find Full Text PDFClin Exp Dermatol
March 2024
Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
This study aimed to retrospectively investigate the association between chilblain lesions and SARS-CoV-2 infection. Our results demonstrate a stronger and more significant association between incidence of chilblain cases and monthly temperature compared with incidence of SARS-CoV-2 infection. These results suggest cold weather was an important risk factor for developing chilblains during the COVID-19 pandemic.
View Article and Find Full Text PDFSemin Arthritis Rheum
December 2023
Tel Aviv University School of Medicine, Israel and Pediatric Rheumatology Unit, Meir Medical Center, Department of Pediatrics, Kfar Saba, Tel Aviv, Israel.
Objective: The COVID-19 pandemic has affected patient care in general. We aimed to analyze the impact of the pandemic on pediatric rheumatology practice.
Methods: An online survey including 22 questions was created by the representatives of the Emerging RheumatoloGists and rEsearchers (EMERGE) group of the Pediatric Rheumatology European Society (PReS) on SurveyMonkey.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!